Sunil Healthcare Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SUNLOC BSE: 537253

₹68.00

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #147 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Sunil Healthcare Limited (this stock)	70	8.1	2.1%	—	—	28	100	43

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹125 Cr

EV / EBITDA

24.1x

EV / Sales

1.49x

Market cap / Sales

0.83x

Earnings yield

12.28%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 19 Cr, down 16.0% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	19	0	—	₹0.5000
March 31, 2026	20	-9	—	₹6.6500
Dec. 31, 2025	22	1	0	₹0.4300
Sept. 30, 2025	24	1	1	₹0.7700
June 30, 2025	23	0	0	₹0.2800
March 31, 2025	21	0	—	₹0.2500
Dec. 31, 2024	20	0	-0	₹-0.0900
Sept. 30, 2024	20	0	0	₹0.0300
June 30, 2024	21	0	0	₹0.0100
March 31, 2024	21	0	0	₹0.0400
Dec. 31, 2023	23	-1	-0	₹-0.3600
Sept. 30, 2023	24	-1	-1	₹-0.9900
June 30, 2023	22	-1	-1	₹-0.7400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	19	20	22	24	23	22	21	20	22	22	26	24	23
Operating revenue	19	20	22	24	23	21	20	20	21	21	23	24	22
Other income	0	0	0	0	0	1	1	0	0	1	3	0	1
Operating expenses	16	17	18	20	19	18	17	17	19	19	23	22	21
Operating profit	3	3	4	4	3	3	3	3	3	3	-1	1	1
Operating profit margin	15.7%	15.9%	16.6%	16.7%	14.5%	13.7%	15.3%	14.2%	13.7%	12.5%	-2.8%	5.0%	4.8%
Depreciation	1	2	2	2	2	2	2	2	1	1	1	2	2
Interest	1	2	2	1	1	2	2	1	2	2	1	1	1
Exceptional items, gain / (loss)	—	-10	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	0	-9	1	1	0	0	0	0	0	0	-1	-1	-1
Tax	-0	-2	0	0	0	-0	0	0	0	0	-0	-0	-0
Net profit	—	—	0	1	0	—	-0	0	0	0	-0	-1	-1
EPS	0.50	6.65	0.43	0.77	0.28	0.25	-0.09	0.03	0.01	0.04	-0.36	-0.99	-0.74
Net profit (TTM)	—	—	—	—	—	—	-0	-0	-1	-2	-2	-2	2
EPS (TTM)	8.35	8.13	1.73	1.21	0.47	0.20	-0.01	-0.28	-1.30	-2.05	-2.14	-1.47	1.71

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 18	Mar 17
Total income (before exceptional items)	-7.8%	-1.4%	89^†	85^†	94^†	113^†	118^†	95^†	85^†	93^†	109^†
Operating revenue	-7.8%	-0.4%	88^†	83^†	90^†	112^†	116^†	90^†	70^†	91^†	107^†
Other income	—	—	1^†	1^†	5^†	2^†	2^†	6^†	15^†	2^†	2^†
Operating expenses	—	—	74^†	72^†	85^†	93^†	98^†	83^†	74^†	—	—
Operating profit	-10.2%	17.8%	14^†	12^†	4^†	19^†	18^†	6^†	-4^†	—	—
Operating profit margin	—	—	15.9%^†	14.2%^†	4.8%^†	17.3%^†	15.3%^†	6.9%^†	-5.9%^†	—	—
Depreciation	—	—	6^†	6^†	6^†	7^†	6^†	6^†	6^†	—	—
Interest	—	—	6^†	6^†	6^†	4^†	3^†	5^†	7^†	5^†	4^†
Exceptional items, gain / (loss)	—	—	-10^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	—	—	-7^†	0^†	-3^†	10^†	10^†	0^†	-2^†	7^†	9^†
Tax	—	—	-2^†	0^†	-1^†	3^†	3^†	0^†	—	2^†	3^†
Net profit	—	—	—	—	-2^†	7^†	7^†	0^†	—	5^†	6^†
EPS	6.1%	97.6%	8.13^†	0.20^†	-2.05^†	6.81^†	6.61^†	0.27^†	-1.47^†	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 18	Mar 17
Operating margin	15.9%^†	14.2%^†	4.8%^†	17.3%^†	15.3%^†	6.9%^†	-5.9%^†	—	—
EBIT margin	-1.0%^†	8.2%^†	3.2%^†	12.5%^†	11.2%^†	6.3%^†	6.7%^†	13.2%^†	12.5%^†
PBT margin	-8.1%^†	0.5%^†	-3.2%^†	8.7%^†	8.2%^†	0.4%^†	-3.2%^†	7.6%^†	8.6%^†
Net margin	—	—	-2.3%^†	6.2%^†	5.8%^†	0.3%^†	—	5.9%^†	5.7%^†
Interest coverage	-0.15x^†	1.06x^†	0.50x^†	3.34x^†	3.74x^†	1.07x^†	0.68x^†	2.37x^†	3.21x^†
Dividend payout	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—
Current ratio	1.09x	1.15x	—	—	—	—	—	—	—
Quick ratio	0.80x	0.88x	—	—	—	—	—	—	—
Debt to equity	0.82x	0.93x	—	—	—	—	—	—	—
Return on equity	—	—	—	—	—	—	—	—	—
Return on assets	—	—	—	—	—	—	—	—	—
Return on capital employed	-0.9%^†	6.5%^†	—	—	—	—	—	—	—
Asset turnover	0.54x^†	0.50x^†	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	22	-3	-19	4	19
March 31, 2025	12	-8	-4	9	2

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	162	68	58	40	16	72	66	0	86	19
March 31, 2025	168	74	63	49	19	71	62	0	94	17

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.